Fibrocell Science, Inc. is a company that specialises in developing autologous cell therapies for skin and connective tissue diseases that have unmet medical needs. Its proprietary autologous fibroblast technology is used in the development of azficel-T, which is currently undergoing Phase II clinical trials for the treatment of vocal cord scarring and restrictive burn scarring.